Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Moderna, Inc.
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
May 26, 2026
Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting
May 26, 2026
Moderna to Present at Upcoming Conferences in May 2026
May 25, 2026
Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting
May 25, 2026
Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026
May 25, 2026
Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026
May 23, 2026
Moderna Resolves Global Patent Litigation with Arbutus/Genevant
May 16, 2026
Dr. David Berman to Join Moderna as Chief Development Officer
January 30, 2026
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
January 29, 2026
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
January 26, 2026
←
Previous Page
1
2
3
Next Page
→